United Biotech Private Limited — Pemetrexed Exporter Profile
Indian Pharmaceutical Exporter · #14 for Pemetrexed · $198.0K export value · DGFT Verified
United Biotech Private Limited is the #14 Indian exporter of Pemetrexed with $198.0K in export value and 41 verified shipments. United Biotech Private Limited holds a 0.7% market share in Pemetrexed exports across 4 countries. The company exports 30 pharmaceutical products worth $7.0M across 7 therapeutic categories.
United Biotech Private Limited — Pemetrexed Export Profile: Buyers & Destinations
Where Does United Biotech Private Limited Export Pemetrexed?
| Country | Value | Shipments | Share |
|---|---|---|---|
| PAKISTAN | $144.5K | 7 | 73.0% |
| NEPAL | $29.9K | 31 | 15.1% |
| UNITED ARAB EMIRATES | $21.0K | 2 | 10.6% |
| SENEGAL | $2.6K | 1 | 1.3% |
United Biotech Private Limited exports Pemetrexed to 4 countries. The largest destination is PAKISTAN accounting for 73.0% of United Biotech Private Limited's Pemetrexed shipments, followed by NEPAL (15.1%) and UNITED ARAB EMIRATES (10.6%). These destinations reflect United Biotech Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Pemetrexed from United Biotech Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| SONERI BANK | PAKISTAN | $144.5K | 7 |
| ZIRVE FZE | UNITED ARAB EMIRATES | $21.0K | 2 |
| M/S. NIKHIL PHARMA PVT. LTD. | NEPAL | $9.0K | 11 |
| NIKHIL PHARMA PVT. LTD. | NEPAL | $8.8K | 11 |
| M S NIKHIL PHARMA PVT LTD | NEPAL | $5.0K | 3 |
| M/S NIKHIL PHARMA PVT.LTD. | NEPAL | $4.3K | 2 |
| PHARMACIE NATIONALE D'APPROVISIONNE | SENEGAL | $2.6K | 1 |
| MS NIKHIL PHARMA PRIVATE LIMITED | NEPAL | $2.0K | 3 |
| NIKHIL PHARMA PVT LTD | NEPAL | $795 | 1 |
United Biotech Private Limited supplies Pemetrexed to 9 buyers globally. The largest buyer is SONERI BANK (PAKISTAN), followed by ZIRVE FZE (UNITED ARAB EMIRATES) and M/S. NIKHIL PHARMA PVT. LTD. (NEPAL). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Pemetrexed Export Value and How Much Does United Biotech Private Limited Contribute?
India exported $20.0M worth of Pemetrexed through 1,209 shipments from 138 suppliers to 92 countries, serving 309 buyers globally. United Biotech Private Limited contributes $198.0K to this total, accounting for 0.7% of India's Pemetrexed exports. United Biotech Private Limited ships Pemetrexed to 4 countries through 9 buyers.
What Is the Average Shipment Value for United Biotech Private Limited's Pemetrexed Exports?
United Biotech Private Limited's average Pemetrexed shipment value is $4.8K per consignment, based on 41 shipments totaling $198.0K. The largest destination is PAKISTAN (73.0% of United Biotech Private Limited's Pemetrexed exports).
How Does United Biotech Private Limited Compare to Other Indian Pemetrexed Exporters?
United Biotech Private Limited ranks #14 among 138 Indian Pemetrexed exporters with a 0.7% market share. The top 3 exporters are FRESENIUS KABI ONCOLOGY LIMITED ($9.0M), EUGIA PHARMA SPECIALITIES LIMITED ($2.4M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($2.0M). United Biotech Private Limited processed 41 shipments to 4 destination countries.
What Pemetrexed Formulations Does United Biotech Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| PHARMA PRODUCT-PEMEXPEMETREXED FOR INJE | $87.4K | 3 |
| PHARMA PRODUCT-PEMEX(PEMETREXED FOR INJE | $21.0K | 2 |
| PHARMA PRODUCT- PEMEX(PEMETREXED FOR INJECTION USP 500 MG) BATCH NO:PELD4B6 MFG:04/2024 EXP:03/2026 | $20.5K | 1 |
| PHARMA PRODUCT-PEMEX 500(PEMETREXED FOR | $14.3K | 2 |
| PHARMA PRODUCT-PEMEX(PEMETREXED FOR INJECTION USP 500 MG) BATCH NO:PELI3B6, MFG:09/023, EXP:08/025VLS | $13.5K | 1 |
| PHARMA PRODUCT PEMEX PEMETREXED INJECTION 500 MG BATCH NO PELK2B5 MFG 11 022 EXP 10 024 | $9.7K | 1 |
| PHARMACEUTICAL MEDICINAL PRODUCTS PEMEX500 Pemetrexed Injection IP 500 mg BATCH. PELL4B1 M:12/2024 EXP:11/2026 | $3.1K | 1 |
| PHARMA PRODUCT-PEMEX 500MG(PEMETREXED FO | $3.0K | 3 |
| PEMEX 100mg,Pemetrexed Inj 100mg,B/N:PEL | $2.6K | 1 |
| PHARMA MEDICINAL PRODUCTS PEMEX 500 Pemetrexed Injection IP 500 mg, B. PELL4B1 MFG DEC-24 EXP NOV-26 | $2.2K | 1 |
United Biotech Private Limited exports 33 distinct Pemetrexed formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMA PRODUCT-PEMEXPEMETREXED FOR INJE with 3 shipments worth $87.4K.
How Does United Biotech Private Limited Compare to Nearest Pemetrexed Exporters?
Exporters ranked immediately above and below #14 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 12 | VEXXA LIFESCIENCES PVT. LTD. | $230.5K | 34 | 1 | $6.8K |
| 13 | SUN PHARMACEUTICAL INDUSTRIES LTD | $203.2K | 9 | 3 | $22.6K |
| 14 | UNITED BIOTECH PRIVATE LIMITED ★ | $198.0K | 41 | 4 | $4.8K |
| 7 | SHILPA MEDICARE LIMITED | $150.0K | 3 | 2 | $50.0K |
| 15 | RUS MED EXPORTS PVT. LTD. | $88.3K | 5 | 1 | $17.7K |
United Biotech Private Limited ranks #14 among 138 Indian Pemetrexed exporters. Average shipment value of $4.8K compared to the market average of $145.0K. The closest competitors by value are VEXXA LIFESCIENCES PVT. LTD. and SUN PHARMACEUTICAL INDUSTRIES LTD.
Which Indian Ports Ship Pemetrexed Exports?
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 209 | 17.3% |
| SAHAR AIR CARGO ACC (INBOM4) | 181 | 15.0% |
| SAHAR AIR | 163 | 13.5% |
| DELHI AIR | 133 | 11.0% |
| CHAWAPAYAL ICD | 43 | 3.6% |
| CHAWAPAYAL ICD (INCPR6) | 41 | 3.4% |
| Bombay Air | 33 | 2.7% |
| HYDERABAD AIR | 32 | 2.6% |
What Other Advanced Oncology Products Does United Biotech Private Limited Export?
United Biotech Private Limited also exports these advanced oncology products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on United Biotech Private Limited's Pemetrexed Exports
The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like United Biotech. The Israel-Iran conflict has escalated tensions in the Middle East, leading to disruptions in Red Sea shipping routes and increased freight costs. The Pharmaceuticals Export Promotion Council of India estimates potential losses between ₹2,500 crore and ₹5,000 crore due to these disruptions, affecting companies reliant on Middle Eastern markets. (telanganatoday.com)
Conversely, the U.S.-China trade tensions have opened avenues for Indian pharmaceutical firms to expand their footprint in the American market. However, recent U.S. tariff policies, including potential increases on pharmaceutical imports, pose a risk to this growth. President Trump's administration has threatened substantial tariff hikes to encourage domestic production, which could impact Indian exporters' competitiveness in the U.S. market. (lemonde.fr)
In the European Union, the implementation of the Falsified Medicines Directive (FMD) necessitates stringent compliance measures for exporters. Indian companies must adapt to these regulatory changes to maintain access to the EU market. The India–EFTA Trade and Economic Partnership Agreement, effective from October 2025, aims to reduce tariffs and promote trade, potentially benefiting exporters like United Biotech. (en.wikipedia.org)
United Biotech Private Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The U.S. FDA, WHO, and EU GMP guidelines set rigorous quality benchmarks that companies must meet to access global markets. While specific regulatory events concerning United Biotech are not detailed, adherence to these standards is essential for sustaining export operations.
The evolving quality requirements, including serialization and traceability mandates under the EU FMD, necessitate continuous investment in compliance infrastructure. Indian exporters must proactively adapt to these changes to ensure uninterrupted market access and maintain their reputation for quality.
About United Biotech Private Limited
United Biotech Private Limited exports 30 products worth $7.0M. Beyond Pemetrexed, top products include Ertapenem, Doxorubicin, Voriconazole, Cisplatin, Methylprednisolone. View the complete United Biotech Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Pemetrexed — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Pemetrexed shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: United Biotech Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 41 individual customs records matching United Biotech Private Limited exporting Pemetrexed, covering 33 formulations to 4 countries via 9 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 92+ countries, 309+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Pemetrexed Export Data from United Biotech Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for United Biotech Private Limited's Pemetrexed exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
United Biotech Private Limited
Full Company Profile →
30 products · $7.0M total trade · 7 categories
Pemetrexed Stats
Company Overview
Top Products by United Biotech Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for United Biotech Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Pemetrexed. For current shipment-level data, contact TransData Nexus.